These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 31443225)

  • 1. Dietary Antioxidant Supplements and Uric Acid in Chronic Kidney Disease: A Review.
    Roumeliotis S; Roumeliotis A; Dounousi E; Eleftheriadis T; Liakopoulos V
    Nutrients; 2019 Aug; 11(8):. PubMed ID: 31443225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of uric acid-lowering therapy on the progression of chronic kidney disease: a systematic review and meta-analysis.
    Liu X; Zhai T; Ma R; Luo C; Wang H; Liu L
    Ren Fail; 2018 Nov; 40(1):289-297. PubMed ID: 29619870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperuricemia and chronic kidney disease: an enigma yet to be solved.
    Dousdampanis P; Trigka K; Musso CG; Fourtounas C
    Ren Fail; 2014 Oct; 36(9):1351-9. PubMed ID: 25112538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time to target uric acid to retard CKD progression.
    Kumagai T; Ota T; Tamura Y; Chang WX; Shibata S; Uchida S
    Clin Exp Nephrol; 2017 Apr; 21(2):182-192. PubMed ID: 27339448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between serum bilirubin levels s and the progression of renal function in patients with chronic kidney disease and hyperuricemia.
    Li M; Li X; Liu Y; Liu X; Song Y; Zhao J; Mohan C; Wu T; Peng A; Qin L
    Clin Chim Acta; 2018 Nov; 486():156-161. PubMed ID: 30076802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal effects of uric acid: hyperuricemia and hypouricemia.
    Park JH; Jo YI; Lee JH
    Korean J Intern Med; 2020 Nov; 35(6):1291-1304. PubMed ID: 32872730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperuricemia and Progression of CKD in Children and Adolescents: The Chronic Kidney Disease in Children (CKiD) Cohort Study.
    Rodenbach KE; Schneider MF; Furth SL; Moxey-Mims MM; Mitsnefes MM; Weaver DJ; Warady BA; Schwartz GJ
    Am J Kidney Dis; 2015 Dec; 66(6):984-92. PubMed ID: 26209544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uric acid as a target of therapy in CKD.
    Jalal DI; Chonchol M; Chen W; Targher G
    Am J Kidney Dis; 2013 Jan; 61(1):134-46. PubMed ID: 23058478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. INTENSITY OF THE ANTIOXIDANT PROTECTION SYSTEM AND OXIDATIVE STRESS FACTORS IN PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS DEPENDING ON THE FORM OF CHRONIC KIDNEY DISEASE.
    Khukhlina O; Antoniv A; Kanovska L; Matushchak M; Vivsyannuk V
    Georgian Med News; 2018 Mar; (276):71-76. PubMed ID: 29697385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma Xanthine Oxidase Activity Is Predictive of Cardiovascular Disease in Patients with Chronic Kidney Disease, Independently of Uric Acid Levels.
    Gondouin B; Jourde-Chiche N; Sallee M; Dou L; Cerini C; Loundou A; Morange S; Berland Y; Burtey S; Brunet P; Guieu R; Dussol B
    Nephron; 2015; 131(3):167-74. PubMed ID: 26426087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An evidence-based review on urate-lowering treatments: implications for optimal treatment of chronic hyperuricemia.
    Bove M; Cicero AF; Veronesi M; Borghi C
    Vasc Health Risk Manag; 2017; 13():23-28. PubMed ID: 28223818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of Chronic Kidney Disease: The Relationship Between Serum Uric Acid and Development of Nephropathy.
    Mende C
    Adv Ther; 2015 Dec; 32(12):1177-91. PubMed ID: 26650815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uric acid and progression of chronic kidney disease.
    Weaver DJ
    Pediatr Nephrol; 2019 May; 34(5):801-809. PubMed ID: 29931555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct radical scavenging activity of benzbromarone provides beneficial antioxidant properties for hyperuricemia treatment.
    Kadowaki D; Sakaguchi S; Miyamoto Y; Taguchi K; Muraya N; Narita Y; Sato K; Chuang VT; Maruyama T; Otagiri M; Hirata S
    Biol Pharm Bull; 2015; 38(3):487-92. PubMed ID: 25757933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uric Acid in Inflammation and the Pathogenesis of Atherosclerosis.
    Kimura Y; Tsukui D; Kono H
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uric acid is not associated with decline in renal function or time to renal replacement therapy initiation in a referred cohort of patients with Stage III, IV and V chronic kidney disease.
    Nacak H; van Diepen M; Qureshi AR; Carrero JJ; Stijnen T; Dekker FW; Evans M
    Nephrol Dial Transplant; 2015 Dec; 30(12):2039-45. PubMed ID: 26185050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New insights into uric acid effects on the progression and prognosis of chronic kidney disease.
    Filiopoulos V; Hadjiyannakos D; Vlassopoulos D
    Ren Fail; 2012; 34(4):510-20. PubMed ID: 22260409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Joint association of hyperuricemia and reduced GFR on cardiovascular morbidity: a historical cohort study based on laboratory and claims data from a national insurance provider.
    Neri L; Rocca Rey LA; Lentine KL; Hinyard LJ; Pinsky B; Xiao H; Dukes J; Schnitzler MA
    Am J Kidney Dis; 2011 Sep; 58(3):398-408. PubMed ID: 21783292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Uric Acid Levels on Kidney Disease Progression.
    Rincon-Choles H; Jolly SE; Arrigain S; Konig V; Schold JD; Nakhoul G; Navaneethan SD; Nally JV; Rothberg MB
    Am J Nephrol; 2017; 46(4):315-322. PubMed ID: 29032376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Daily Intake of Grape Powder Prevents the Progression of Kidney Disease in Obese Type 2 Diabetic ZSF1 Rats.
    Almomen SM; Guan Q; Liang P; Yang K; Sidiqi AM; Levin A; Du C
    Nutrients; 2017 Mar; 9(4):. PubMed ID: 28362355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.